SNDX
Syndax Pharmaceuticals, Inc. · Healthcare
Director Keith Katkin sold $103K of Syndax Pharmaceuticals, Inc.
Sold$102,777
$25.06Price
4,101Shares
−11%Stake
What SNDX did after the filing
- The stock from Wed, Oct 5 open, $24.80
- −15.5%
- S&P 500, same days
- +5.9%
Measured over 30 trading days, to the Nov 16 close.
Traded Fri, Sep 30. Filed Tue, Oct 4, 5:49 PM ET, after the close. Returns use the Oct 5 open and the Nov 16 close. Not investment advice.